Revival Research Institute, LLC.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease1 trial
• Heart failure1 trial
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Boehringer Ingelheim1 trial
• Pfizer1 trial

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

  NCT06897202· Phase 2· Pfizer· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source